Literature DB >> 6311851

Reduced free-methionine in methionine-dependent SV40-transformed human fibroblasts synthesizing apparently normal amounts of methionine.

P H Stern, J O Mecham, C D Wallace, R M Hoffman.   

Abstract

Many different types of cancer cells have been shown to be methionine-dependent. These cells, unlike normal cells, grow poorly or not at all when methionine is replaced by its immediate precursor homocysteine in the growth medium (Met- Hcy+ medium). We have previously shown that apparently normal total amounts of methionine are synthesized by methionine-dependent SV40-transformed human fibroblasts. However, methionine-dependent cells in Met- Hcy+ medium accumulate reduced amounts of S-adenosylmethionine (AdoMet) and elevated amounts of S-adenosylhomocysteine (AdoHcy) that together probably limit growth. In this report, we demonstrate that the amount of free methionine is low in methionine-dependent SV40-transformed human fibroblasts in Met- Hcy+ medium compared to normal human diploid fibroblasts. In contrast, in Met+ Hcy- medium, the amount of free methionine is comparable in both cell types. The deficient pool of free methionine in methionine-dependent cells in Met- Hcy+ medium allows only low amounts of AdoMet to be formed. However, large amounts of the biosynthesized methionine are channeled into protein synthesis. Possible mechanisms are discussed to explain this cancer-associated metabolic defect.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311851     DOI: 10.1002/jcp.1041170103

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.

Authors:  Kei Kawaguchi; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Bartosz Chmielowski; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Arun S Singh; Mark A Eckardt; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-03-19       Impact factor: 4.534

2.  Unchecked DNA synthesis and blocked cell division induced by methionine deprivation in a human prostate cancer cell line.

Authors:  H Y Guo; R M Hoffman; H Herrera
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

3.  Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.

Authors:  Shuya Yano; Kiyoto Takehara; Ming Zhao; Yuying Tan; Qinghong Han; Shukuan Li; Michael Bouvet; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Cell Cycle       Date:  2016-05-06       Impact factor: 4.534

4.  Oral recombinant methioninase combined with paclitaxel arrests recalcitrant ovarian clear cell carcinoma growth in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.

Authors:  Norihiko Sugisawa; Takashi Higuchi; Qinghong Han; Chihiro Hozumi; Jun Yamamoto; Yoshihiko Tashiro; Hiroto Nishino; Kei Kawaguchi; Michael Bouvet; Takuya Murata; Michiaki Unno; Robert M Hoffman
Journal:  Cancer Chemother Pharmacol       Date:  2021-03-25       Impact factor: 3.333

5.  Deletion of MTAP Highly Sensitizes Osteosarcoma Cells to Methionine Restriction With Recombinant Methioninase.

Authors:  Yusuke Aoki; Yasunori Tome; Qinghong Han; Jun Yamamoto; Kazuyuki Hamada; Noriyuki Masaki; Yutaro Kubota; Michael Bouvet; Kotaro Nishida; Robert M Hoffman
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

6.  Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.

Authors:  Kentaro Igarashi; Kei Kawaguchi; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Shukuan Li; Qinghong Han; Yuying Tan; Ming Zhao; Yunfeng Li; Scott D Nelson; Sarah M Dry; Arun S Singh; Irmina A Elliott; Tara A Russell; Mark A Eckardt; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Shinji Miwa; Hiroyuki Tsuchiya; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-04-10       Impact factor: 4.534

7.  De novo engineering of a human cystathionine-γ-lyase for systemic (L)-Methionine depletion cancer therapy.

Authors:  Everett Stone; Olga Paley; Jian Hu; Barbara Ekerdt; Nai-Kong Cheung; George Georgiou
Journal:  ACS Chem Biol       Date:  2012-09-21       Impact factor: 5.100

8.  Elevated overall rates of transmethylation in cell lines from diverse human tumors.

Authors:  P H Stern; R M Hoffman
Journal:  In Vitro       Date:  1984-08

9.  Oral Methioninase Inhibits Recurrence in a PDOX Mouse Model of Aggressive Triple-negative Breast Cancer.

Authors:  Hye In Lim; Kazuyuki Hamada; Jun Yamamoto; Qinhong Han; Yuying Tan; Hee Jun Choi; Seok Jin Nam; Michael Bouvet; Robert M Hoffman
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

10.  Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction.

Authors:  Jun Yamamoto; Yusuke Aoki; Sachiko Inubushi; Qinghong Han; Kazuyuki Hamada; Yoshihiko Tashiro; Kentaro Miyake; Ryusei Matsuyama; Michael Bouvet; Steven G Clarke; Itaru Endo; Robert M Hoffman
Journal:  Cancer Genomics Proteomics       Date:  2022 Jan-Feb       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.